Sinco Pharmaceuticals Holdings Limited (HKG:6833)

HKG:6833 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	254.58	249.2	308.32	437.92	329.14	326.05
Cash & Short-Term Investments	254.58	249.2	308.32	437.92	329.14	326.05
Cash Growth	9.44%	-19.18%	-29.59%	33.05%	0.95%	126.79%
Accounts Receivable	749.46	591.57	608.25	540.51	351.27	213.6
Other Receivables	-	52.76	72.03	51.88	37.74	10.35
Receivables	749.46	644.33	680.28	592.38	389.01	223.96
Inventory	335.91	259.56	352.53	108.03	89.58	62.76
Prepaid Expenses	-	-	-	-	-	1.3
Restricted Cash	114.89	125.18	103.06	220.03	107.85	55.02
Other Current Assets	160.37	76.4	68.02	74.93	101.82	299.9
Total Current Assets	1,615	1,355	1,512	1,433	1,017	968.98
Property, Plant & Equipment	353.19	359.1	371.36	354.21	315.84	256.26
Goodwill	66.54	66.54	66.54	66.54	66.54	-
Other Intangible Assets	64.5	8.73	11.81	14.03	15	-
Long-Term Deferred Tax Assets	5.3	4.2	2.42	3.4	3	0.86
Long-Term Deferred Charges	-	47.92	30.14	13.08	-	-
Other Long-Term Assets	5.7	5.78	5.96	6.14	6.55	6.67
Total Assets	2,110	1,847	2,000	1,891	1,424	1,233

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,201	912.22	887.97	866.59	407.99	422.93
Accrued Expenses	-	12.06	14.67	17.13	86.11	17.49
Short-Term Debt	-	179.72	340	240	180.81	207.51
Current Portion of Long-Term Debt	111.8	-	0.86	0.86	-	0.81
Current Portion of Leases	1.94	3.19	5.14	3.83	3	0.38
Current Income Taxes Payable	20.96	17.13	20.59	26.44	5.44	12.83
Current Unearned Revenue	10.64	18.85	27.73	40.46	75.43	27.75
Other Current Liabilities	48.93	8.33	34.7	36.73	31.82	35.93
Total Current Liabilities	1,396	1,151	1,332	1,232	790.59	725.64
Long-Term Debt	-	-	0.05	0.89	0.92	132.24
Long-Term Leases	3.04	0.49	4.49	5.83	7.69	-
Long-Term Deferred Tax Liabilities	0.68	0.9	1.35	1.8	2.25	-
Other Long-Term Liabilities	-	-	-	22.08	19.08	-
Total Liabilities	1,399	1,153	1,338	1,263	820.52	857.88

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.16	0.16	0.16	0.16	0.16	0.15
Additional Paid-In Capital	-	529.48	529.48	529.48	529.48	370.02
Retained Earnings	-	164.42	133.24	98.41	74.17	0.48
Comprehensive Income & Other	710.85	-	-	-	-	4.23
Total Common Equity	711.01	694.06	662.88	628.05	603.81	374.89
Shareholders' Equity	711.01	694.06	662.88	628.05	603.81	374.89
Total Liabilities & Equity	2,110	1,847	2,000	1,891	1,424	1,233

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	116.78	183.39	350.54	251.4	192.41	340.95
Net Cash (Debt)	137.81	65.81	-42.22	186.52	136.73	-14.9
Net Cash Growth	2815.89%	-	-	36.41%	-	-
Net Cash Per Share	0.07	0.03	-0.02	0.09	0.07	-0.01
Filing Date Shares Outstanding	2,033	2,033	2,033	2,033	2,033	1,873
Total Common Shares Outstanding	2,033	2,033	2,033	2,033	2,033	1,873
Working Capital	219.5	203.18	180.55	201.25	226.82	243.34
Book Value Per Share	0.35	0.34	0.33	0.31	0.30	0.20
Tangible Book Value	579.97	618.79	584.53	547.49	522.28	374.89
Tangible Book Value Per Share	0.29	0.30	0.29	0.27	0.26	0.20
Buildings	-	214.5	214.5	196.87	197.31	197.31
Machinery	-	60.23	58.89	25.98	22.94	20.06
Construction In Progress	-	76.36	68.04	107.3	84.58	33.5
Leasehold Improvements	-	36.55	36.32	13.67	11.19	11.08

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error